Ticker Symbol: PRPO
Precipio Inc
$2.06 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001043961
Company Profile
Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide, as well as proprietary products that serve laboratories worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care.
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3826
Address: 12325 Emmet St
Website: www.precipiodx.com
CEO: Paul Kinnon
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Analytical Laboratory Instrument Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $5.93
Change:
$0.19
(
3.40%)
Days Range: $5.67 - $6.16
Beta: 0.43
52wk. High: $20.48
52wk. Low: $4.75
Ytd. Change -44.55%
50 Day Moving Average: $6.29
200 Day Moving Average: $8.72
Shares Outstanding: 27562298
Valuation
Market Cap: 16.4B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A